Apellis Pharmaceuticals to Host a Fireside Chat at the Jefferies London Healthcare Conference
Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in the Jefferies London Healthcare Conference. The company will host a fireside chat on Tuesday, November 19, 2024, at 8:30 a.m. GMT. The event will be accessible through a live webcast on the company's website under the 'Events and Presentations' page in the 'Investors and Media' section. Interested parties can access a replay of the webcast, which will remain available for approximately 90 days after the event.
Apellis Pharmaceuticals (Nasdaq: APLS) ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference. L'azienda ospiterà una chiacchierata informale martedì 19 novembre 2024, alle 8:30 GMT. L'evento sarà accessibile tramite una trasmissione in diretta sul sito web dell'azienda nella pagina 'Eventi e Presentazioni' nella sezione 'Investitori e Media'. Le parti interessate potranno accedere a una registrazione della trasmissione, che rimarrà disponibile per circa 90 giorni dopo l'evento.
Apellis Pharmaceuticals (Nasdaq: APLS) ha anunciado su participación en la Conferencia de Salud de Jefferies en Londres. La empresa llevará a cabo una charla informal el martes 19 de noviembre de 2024, a las 8:30 a.m. GMT. El evento será accesible a través de una transmisión en vivo en el sitio web de la empresa en la página 'Eventos y Presentaciones' en la sección 'Inversores y Medios'. Las partes interesadas podrán acceder a una repetición de la transmisión, que estará disponible durante aproximadamente 90 días después del evento.
아펠리스 제약 (Nasdaq: APLS)은 제퍼리스 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 2024년 11월 19일 화요일 오전 8시 30분 GMT에 파이어사이드 채팅을 주최할 예정입니다. 이 행사에는 회사 웹사이트의 '이벤트 및 발표' 페이지의 '투자자 및 미디어' 섹션에서 생중계로 접근할 수 있습니다. 관심 있는 분들은 행사 후 약 90일 동안 이용 가능한 웹캐스트의 녹화 영상을 볼 수 있습니다.
Apellis Pharmaceuticals (Nasdaq: APLS) a annoncé sa participation à la Conférence de Santé Jefferies de Londres. L'entreprise animera une discussion informelle le mardi 19 novembre 2024 à 8h30 GMT. L'événement sera accessible via un webcast en direct sur le site web de l'entreprise, dans la page 'Événements et Présentations' de la section 'Investisseurs et Médias'. Les parties intéressées pourront accéder à un replay du webcast, qui restera disponible pendant environ 90 jours après l'événement.
Apellis Pharmaceuticals (Nasdaq: APLS) hat seine Teilnahme an der Jefferies London Healthcare Conference bekannt gegeben. Das Unternehmen wird am Dienstag, den 19. November 2024, um 8:30 Uhr GMT einen Fireside-Chat veranstalten. Die Veranstaltung wird über einen Live-Webcast auf der Unternehmenswebsite unter der Seite 'Veranstaltungen und Präsentationen' im Bereich 'Investoren und Medien' zugänglich sein. Interessierte Parteien können eine Wiederholung des Webcasts abrufen, die etwa 90 Tage nach der Veranstaltung verfügbar bleibt.
- None.
- None.
WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:30 a.m. GMT.
The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178
FAQ
When is Apellis Pharmaceuticals (APLS) presenting at the Jefferies London Healthcare Conference 2024?
How long will the Apellis (APLS) Jefferies Conference webcast replay be available?
Where can I watch Apellis Pharmaceuticals' (APLS) Jefferies Conference presentation?
